Type : Bid Notification
B2300079 - B2300079 Agent-based Micro-Segmentation Firewall for Servers postdate:- 02/23/2023 responsedate:- 04/05/2023 10:00 AM MDT Solicitation Number:- B2300079 to solicitation details & future business opportunities.
B2300079 - B2300079 Agent-based Micro-Segmentation Firewall for Servers postdate:- 02/23/2023 responsedate:- 04/05/2023 10:00 AM MDT Solicitation Number:- B2300079 to solicitation details & future business opportunities.
Bid Number: AGENT-BASED CORE DEVELOPMENT AND CAPABILITIES (ACDC)Bid Title:Post Date: 2019-10-16Due Date: 2019-10-30Solicitation Type:Category: 541 -- Professional, Scientific, and Technical Services/541715 -- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Address: 26 Electronic Parkway Rome, New York 13441-4514 United States
Support will include the development of high quality analytical products using a multitude of event-driven and agent-based modeling and simulation tools. Tasking under this effort will also address broader issues facing the Fleet at-large including evaluations of future force structures and ship classes using a combination of analytical processes and agent-based tools, including analysis of alternatives and support to future shipbuilding pans.
This requirement includes performing complex agent-based modeling activities, quality management, and professional services in research.
BASED FIRE SUPPRESSION SYSTEM Work DescriptionDESIGN, ENGINEERING, SUPPLY, INSTALLATION, TESTING AND COMMISSIONING OF FIRE DETECTION CUM CLEAN AGENT BASED FIRE SUPPRESSION/ EXTINGUISHING FLOODING SYSTEM AT PIPELINE INSTALLATIONS UNDER AGRA AND MALANPUR REGION ON BUY BACK BASISNDA/Pre QualificationPlease refer Tender documents.Independent External Monitor/RemarksNATender Value in ₹ NAProduct CategoryMiscellaneous Works Sub categoryNA Contract TypeTenderBid
Diagnostics assays that leverage electrochemical-based sensors may focus on host biomarkers, agent-based analytes (e.g. intact agent, metabolites, protein adducts), and binding activity (e.g. immunoassays, agent-target interaction). Sample types shall be minimally invasive (e.g. saliva, sweat, capillary blood). Novel approaches not included above are also encouraged and welcomed to respond to this RFI.